when will the Vertiflex Reps begin selling Stim?

Discussion in 'Boston Scientific' started by anonymous, May 15, 2019 at 10:01 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    They've got the same "target" group + surgeons.
     

  2. anonymous

    anonymous Guest

    Doubt they'd combine bags despite calling on the same docs..
     
  3. anonymous

    anonymous Guest

    Most are former stim reps with same POC. V rep wages not on par with stim reps. Expect that to change. So many stim company’s now and more on the way too enter the market. Boots on the ground. Changes are coming!
     
  4. anonymous

    anonymous Guest

    I didn't sign up for selling leads and cans again! If and when that happens, I'm gone!
     
  5. anonymous

    anonymous Guest

    Surgeons do not use Vertiflex. It is all pain management.

    The real question is:
    Should medtronic dust off the x-stop (basically the same thing as Superion, it was the comparable device in tthe PMA) and unload it for a couple hundred million to Abbott, St Jude, Nevro, or even let their stim reps sell it. They shelved it because of the expense of the continued post study monitoring while sales declined, and the embarrassment of such a crappy product with their name it.
     
  6. anonymous

    anonymous Guest

    even more interesting is to look at the approval pathway for Superion:

    1) showed non superiority to x-stop
    2) x-stop removed from the market during the study
    3) x-stop showed non-inferiority to conservative care for its approval

    So,
    Superion is no worse than a x-stop, that is no worse then conservative care, and was removed from the market.

    hmmmmm.......
     
  7. anonymous

    anonymous Guest

    Lots of Vertiflex reps will be let go. Always the case when acquired. Boston Sci will roll it into their reps, which they feel is a much more professional sales organization.
     
  8. anonymous

    anonymous Guest

    Not exactly.... A non-inferiority trial is just a simpler and more efficient way to obtain FDA approval. The goal is to get it to market as quickly as possible and TONS of devices are approved this way.
     
  9. anonymous

    anonymous Guest

    They had to do a PMA. The comparison was x-stop. Period STOP.

    They are marketing better and Bos Sci doesn't have to worry about all the real spine surgeons getting turned off, like Medtronic did, while they push a very narrowly indicated procedure to pain management hacks who will put it in everyone they can.

    Surgeon do not believe! Pain management will slam these in and piss off their patients. They will fail and the pt will be out because they paid cash and they have almost no commercial coverage. Already lots have come in out of patients in less than a year when they don't work and they see a real spine specialist, not a hack with his own ASC.
     
  10. anonymous

    anonymous Guest

    less than 1% of medical devices are approved by FDA PMA. Most are 510K. "TONS", you need to learn what your talking about.

    Read the minutes from the FDA vote. Was close vote with some reservations.
     
  11. anonymous

    anonymous Guest

    Thanks for your input Dr Caraway
     
  12. anonymous

    anonymous Guest

    This statement right here is 100% correct. Pain docs are stretching the narrow indication and throwing these in patients left and right for a quick dollar. They are doing the same with si-fusion products too. Hey pain docs, if you want to be a surgeon, go do a surgeon fellowship. Otherwise, stay in your lane and continue being a needle-jockey.

    I expect a "major correction" and bitch slap from CMS pretty soon.

    And then the "expert" consultant/speakers will whore themselves out for the next "niche" product.
     
  13. anonymous

    anonymous Guest

    Whats going on with Vertiflex? Docs dropping it in masses.